000 01229 a2200349 4500
005 20250512040925.0
264 0 _c19881220
008 198812s 0 0 eng d
022 _a0016-5085
024 7 _a10.1016/s0016-5085(88)80084-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaumann, A J
245 0 0 _aICI 169,369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertensive rats.
_h[electronic resource]
260 _bGastroenterology
_cDec 1988
300 _a1601-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aHypertension, Portal
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPortal System
_xdrug effects
650 0 4 _aQuinolines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Serotonin
_xdrug effects
650 0 4 _aSerotonin
_xphysiology
650 0 4 _aSerotonin Antagonists
_xpharmacology
700 1 _aMorgan, J S
700 1 _aGroszmann, R J
773 0 _tGastroenterology
_gvol. 95
_gno. 6
_gp. 1601-6
856 4 0 _uhttps://doi.org/10.1016/s0016-5085(88)80084-2
_zAvailable from publisher's website
999 _c3187468
_d3187468